Doesn’t follow this company, but only knows about up because it has gone up so much. Basically, they are using oats and bran malt for different applications, biotech, cosmetics, etc. Very early stage. Revenue growth is very, very high, but it is coming from a very small base. Revenue expectations are in the $20 million range, on a market cap of $145 million. Expectations are so high here, it’s early stage, and it’s a developing company. Investors need a splash of cold water, because they have jacked up the price so high. A decent little company, but just a crazy valuation.

The renewable space is starting to get a lot of attention and has recovered quite nicely. There have been some takeover plays in the space, and there are other companies up for sale. This one is kind of in the sights of Brookfield, and they don’t like paying too much for companies. There is a bit of a hurdle because of this company’s parent share ownership. This is a decent income play.

This has flight data recorders that go into airplanes, and it is a hard, hard sale to get airlines to put in a $100,000 product, even though it is going to save them money and is a good product. Probably still a little too early. The growth is nice to see, but the market cap is a little too small to get a lot of attention.

Investors are very, very concerned about the company, but are concerned for the wrong reasons. They are concerned because it is being attacked, because there are no press releases, and because it is going down. He doesn’t think that because it is down is a good reason to Sell. The last quarter was a miss, but there is a valuable business there, and the company is up for sale, and is trading at 2X earnings. Certainly the company has to do an improved job in communications.

Thinks this company is destined to be privatized. Trading at about 9 or 10 times earnings, pays a really nice dividend, insiders own a big chunk, and business is pretty good. You have other leasing companies that are trading at much higher valuations. No one is really paying attention to this and it doesn’t trade a whole lot. He thinks that eventually a private equity group or management might consider taking it private. Dividend yield of 7.8%.

Just reported and earnings were decent, and also made an acquisition which created more interest. The stock has had a really tough time of it, of course being in the healthcare sector with Valeant (VRX-T) and Concordia (CXR-T). They also have accounting issues which is not good. They really need to get a big 6 accounting firm and get rid of the smaller one. Not his favourite company, but the valuation is attractive enough, so it is interesting. He would like to see a couple of more quarters.

Management knows exactly what they are doing in the sector, and now they are going to expand outside of Canada. You have to give them points for a really consistent execution. They have done almost nothing wrong since they re-emerged as a public company. Have completely dominated their niche and there are still opportunities. If management is going to expand, you want to ride that train with them.